repurposing existing drugs for covid-19 a less rapid alternative to a vaccine, say researchers
repurposing existing drugs for covid-19 a less rapid alternative to a vaccine, say researchers
although clinical trials found it to be insufficiently effective at treating ebola, clinical trials in the usa have suggested the drug may be beneficial for treating patients hospitalised with covid-19, and the fda has now approved it for emergency use.", "> \"[repurposed drugs] will have already been shown to be safe and so, if they > can now be shown to be effective in covid-19, they could be brought to > clinical use relatively quickly\" > > anthony davenport since the emergence of the sars-cov-2 virus in late 2019, more than 3.5 million people are known to have been infected, leading to over 240,000 deaths worldwide from covid-19, the disease caused by the novel coronavirus.", 


































"while we're waiting for a vaccine, drugs currently being used to treat other illnesses can be investigated as treatments for covid-19  in other words repurposed, said dr steve alexander from the university of nottingham.", "these treatments will have already been shown to be safe and so, if they can now be shown to be effective in covid-19, they could be brought to clinical use relatively quickly. one promising candidate is remdesivir, a drug originally developed for ebola.")